Source: Health Canada shortage reports · Updated Oct 23, 2026
Some Colesevelam products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 11, 2026.
A bile acid sequestrant used to lower cholesterol and help control blood sugar in type 2 diabetes.
Products affected
1 / 3
In shortage since
Oct 19, 2026
Est. full return
Dec 11, 2026
Reports on file
18
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-COLESEVELAM
625MG · TABLET · APOTEX INC
DIN 02494051 · since Oct 19, 2026, est. end Dec 11, 2026 · Disruption of the manufacture of the drug.
Discontinued
LODALIS
3.75G · POWDER FOR SUSPENSION · BAUSCH HEALTH, CANADA INC.
DIN 02432463
Resolved
APO-COLESEVELAM
625MG · TABLET · APOTEX INC
DIN 02494051 · ended Jun 26, 2024 · Disruption of the manufacture of the drug.
Resolved
LODALIS
625MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02373955 · ended Mar 25, 2024 · Delay in shipping of the drug.
Resolved
LODALIS
625MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02373955 · ended Jul 29, 2024 · Reagent required for drug product release testing out of stock
Resolved
APO-COLESEVELAM
625MG · TABLET · APOTEX INC
DIN 02494051 · ended Dec 21, 2023 · Disruption of the manufacture of the drug.
Resolved
LODALIS
3.75G · POWDER FOR SUSPENSION · BAUSCH HEALTH, CANADA INC.
DIN 02432463 · ended Dec 1, 2023 · Shortage of an inactive ingredient or component.
Resolved
APO-COLESEVELAM
625MG · TABLET · APOTEX INC
DIN 02494051 · ended Jul 26, 2023 · Disruption of the manufacture of the drug.
Resolved
LODALIS
625MG · TABLET · BAUSCH HEALTH, CANADA INC.
DIN 02373955 · ended Mar 3, 2023 · waiting QA release
Resolved
APO-COLESEVELAM
625MG · TABLET · APOTEX INC
DIN 02494051 · ended Feb 8, 2023 · Disruption of the manufacture of the drug.
Avoided
LODALIS
3.75G · POWDER FOR SUSPENSION · BAUSCH HEALTH, CANADA INC.
DIN 02432463 · ended Aug 1, 2022 · Shortage of an inactive ingredient or component.
Resolved
APO-COLESEVELAM
625MG · TABLET · APOTEX INC
DIN 02494051 · ended Mar 30, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 18 reports. All reports are on file with Health Canada.
What's happening
Colesevelam is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Colesevelam is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AC).
Recent changes
Oct 23, 2026
New report filed
Common questions
What is Colesevelam used for?
A bile acid sequestrant used to lower cholesterol and help control blood sugar in type 2 diabetes.
When will Colesevelam be back in stock in Canada?
The latest manufacturer estimate is Dec 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Colesevelam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.